Im-Encap 100 mg Capsule is a Health Canada–registered human drug (DIN 02240534) held by Thorne Research Canada Ltd., containing Sambucus Nigra. Health Canada lists its status as Cancelled (Unreturned Annual) (status date 23 Mar 2018). Nexara Health has matched 9 registrations of Sambucus Nigra across 2 other regulated markets.
Health Canada registration
| DIN | 02240534 |
|---|---|
| Brand name | Im-Encap |
| Active ingredient | Sambucus Nigra |
| Strength | 100 mg |
| Dosage form | Capsule |
| Route | Oral |
| Company | Thorne Research Canada Ltd. |
| Status | Cancelled (Unreturned Annual) — 23 Mar 2018 |
| Class | Human |
| ATC | |
| AHFS | 92:01.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Sambucus Nigra registered in other markets
9 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | VITAHERB Berrycol Syrup (Original Flavour) | Winwa Medical Sdn. Bhd. | Natural Product | PRODUCT APPROVED | NPRA | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sambucus Nigra | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Sambucus Nigra worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Im-Encap (DIN 02240534) marketed in Canada?
No. Health Canada lists DIN 02240534 as Cancelled (Unreturned Annual) as of 23 Mar 2018.
Who holds the Canadian licence for this product?
Thorne Research Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Sambucus Nigra registered outside Canada?
Yes — Nexara Health has matched 9 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02240534, status date 2018-03-23; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02240534, status date 2018-03-23; national medicine registries: FDA NDC, NPRA.
Health Canada Drug Product Database (DPD), DIN 02240534, status date 2018-03-23; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.